GLENMARK PHARMACEUTICALS SK, s. r. o.
ActiveKey figures
Key figures
2026Summary: GLENMARK PHARMACEUTICALS SK, s. r. o.
What kind of company is it?
GLENMARK PHARMACEUTICALS SK, s. r. o. (IČO 35933526) is a limited liability company (s.r.o.). The company was incorporated in 2005 and has existed for 21 years. Registered office according to the register: Bratislava. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 25–49 employees.
Who runs the company and who owns it?
The statutory body has 3 members. According to the register, the company has one shareholder. The registered capital is 6 639 €.
How is the company doing financially?
Revenue for 2026 was 16 607 346 €, down 17,6 % on the previous year (20 153 595 €). From 2021 to 2026, revenue grew by an average of 6,6 % per year. Net profit for 2026 was 112 693 € (0,7 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2026 were 2 135 870 €. At the end of 2026 the company had total assets of 9 693 261 € and equity of 3 276 134 € (equity ratio 33,8 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 17. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2021–2026
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 13 631 760 | 15 335 606 | 17 786 010 | 20 153 595 | 16 607 346 |
| Profit for the reporting year | 276 603 | 498 040 | 197 881 | 1 070 253 | 112 693 |
| Retained earnings of previous periods | -86 638 | 189 965 | 688 005 | 885 886 | 1 956 138 |
| Total assets | 6 654 206 | 8 188 578 | 9 439 324 | 8 937 726 | 9 693 261 |
| Total liabilities | 5 256 938 | 6 293 270 | 7 346 135 | 5 774 284 | 6 417 127 |
| Total equity | 1 397 268 | 1 895 308 | 2 093 189 | 3 163 442 | 3 276 134 |
| Calculated dividends | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements20
- 2026 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2026 Správa audítora
- 2026 Úč POD · 12 pp.
- 2026 Úč POD
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Správa audítora
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Správa audítora
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Správa audítora
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Správa audítora
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- MagnaPharm SK s. r. o. · Bratislava - mestská časť Petržalka
- Slovakiapharm, a.s. · Nové Zámky
- ZAR Services, s. r. o. · Svätý Jur
- CURADEN Slovakia s.r.o. · Bratislava - mestská časť Ružinov
- Neuraxpharm Slovakia, a. s. · Bratislava
- MedaPreX SK, s.r.o. · Bratislava
- PHARMOS, a.s. v konkurze · Nitra
- MEDIC LABOR, s.r.o. · Banská Bystrica
- Slovenská zooveterinárna homeopatická spoločnosť, s.r.o. · Lučenec
- TRANSMEDIC SLOVAKIA, s.r.o. „v konkurze“ · Banská Bystrica